About Richard Chin
Richard Chin is a director at Cytek Biosciences.
Form D filings name Richard Chin as a co-founder, chair of the board at VETmAb BIO and a director at Bio Usawa.
Richard Chin reports to the SEC as a director, officer or major shareholder of 5 public companies, including Kindred Biosciences (KIN), SELLAS Life Sciences Group (SLS) and ImmunoCellular Therapeutics (IMUC).
Richard Chin first appears on SEC filings in 2006.
Experience
This experience comes from Richard Chin's profile and from SEC filings. For roles taken from filings, the years are when the filings name Richard Chin in the role, so the role may have started earlier or lasted longer.
ES
Elixxir Life Science Current
Founder and CEO
2026 – Present
CI
Cytek Biosciences, Inc. Current
Director
2025 – Present · Public company (CTKB)
Bio Usawa Inc. Current
Co-Founder and Chairman of the Board of Directors
2023 – Present · San Francisco, CA
Vetmab Biosciences, Inc. Current
Co-founder, Chair of the Board
Co-Founder and Chairman of the Board of Directors (2022 – Present)
2022 – Present · San Diego, CA
Develops antibody treatments for veterinarians caring for dogs and cats.
AV
Ascendant Venture Current
Managing Director
2022 – Present
CM
Center for Asian American Media Current
Board Member
2021 – Present
WI
Wikitongues
Board Member
2021 – 2023
KI
Kindred Biosciences, Inc.
Chief Executive Officer and director
2013 – 2021 · Public company (KIN)
KI
KindredBio
Founder and Chief Executive Officer
2012 – 2021
UF
University of California, San Francisco
Clinical Associate Professor
2010 – 2020
BI
Balance Therapeutics Inc.
Board Member
2011 – 2018
SI
SELLAS Life Sciences Group, Inc.
Director
2009 – 2017 · Public company (SLS)
IL
ImmunoCellular Therapeutics, Ltd.
Director
2012 – 2014 · Public company (IMUC)
CB
Caribou Biosciences
Board Member
2013 – 2014
GT
Genmedica Therapeutics
Board Member
2004 – 2012
IH
Institute for OneWorld Health
Chief Executive Officer
2008 – 2011
OI
Oncotelic Therapeutics, Inc.
President and CEO, director
2006 – 2008 · Public company (OTLC)
OI
Oxigene, Inc.
Chief Executive Officer
2006 – 2008
EI
Elan Pharmaceuticals, Inc.
Senior Vice President, Global Development
2004 – 2006
GE
Genentech
Head of Clinical Research, Biotherapeutics Unit
1999 – 2004
GE
genente
Head of Clinical Research, Cardiovascular Group
2001 – 2002
GE
genent
Sr. Clinical Scientist
2001
Key Colleagues at Startups
The people Richard Chin works with at each company, as listed on that company's latest Form D.
Vetmab Biosciences, Inc. · Form D, Sep 29, 2026
Denise Bevers
Co-founder, President & CEO, Board Member
Hangjun Zhan
Director
NA
Neeraj Agrawal
Director
CM
Chrysa Mineo
Director
Bio Usawa Inc. · Form D/A, Jan 27, 2026
VA
Vincent Ancinetti
Director
JH
John Hautman
Chief Legal Officer
MB
Menghis Bairu
Executive officer and director